fundsforNGOs

CTR Global Biosecurity Engagement Activities

CTR Global Biosecurity Engagement Activities

Deadline: 31-Jan-24

The Department of State’s Bureau of International Security and Nonproliferation, Office of Cooperative Threat Reduction (ISN/CTR) is pleased to announce an open competition for assistance awards through this Notice of Funding Opportunity (NOFO).

ISN/CTR administers the Biosecurity Engagement Program (BEP) as part of the Global Threat Reduction (GTR) portfolio. BEP’s national security mission is to mitigate global biological threats by securing and/or protecting against the misuse of high consequence pathogens, synthetic biological materials, biotechnologies, genomic data, life sciences research, laboratory infrastructure, and related equipment for biological weapons (BW) purposes, and helping foreign partners develop biosecurity policy, guidance and technical capabilities at the national and regional levels to promote the adoption or compliance with international best practices and frameworks that advance U.S. biological nonproliferation objectives.

BEP addresses several BW-related proliferation challenges. First, government, academic, and private sector research entities conducting advanced microbiology, toxicology, and genomic research and/or deploying biotechnologies, as well as physical and digital biorepositories, have expertise, access to, or house BW-applicable materials, equipment, data, tools, and information that is vulnerable to exploitation by state or non-state actors seeking to advance BW efforts continues to increase every year. The pandemic has led to an increased number of laboratories worldwide, and without proper security measures and training, these laboratories and their staff are vulnerable to exploitation. Laboratories and researchers around the world continue to be approached by malign actors seeking research collaboration or investment opportunities.

Additionally, the frequency of cyber-attacks has steadily increased worldwide, and malicious exploitation of cyber vulnerabilities of life sciences infrastructure could result in data and research theft and negatively impact the safe and secure operations of laboratories housing high consequence pathogens. Furthermore, rapid advancements in synthetic biology and the abundant availability of related research publications are lowering the technical threshold to modify genetic material, and enabling dangerous types of research which could result in modified pathogens with increased transmissibility, survivability, ability to evade detection, or other BW-applicable modifications.

Program Objectives
Funding Information
Priority Region
Participants and Audiences
Eligibility Criteria

For more information, visit Grants.gov.

Exit mobile version